|
Would you like to ask us a medical question?
|
Soy

Soy (Glycine max L. Merr.)
BackgroundSoy is a subtropical plant, native to southeastern Asia. This member of the pea family (Fabaceae) grows from one to five feet tall and forms clusters of three to five pods, each containing two to four beans per pod. Soy has been a dietary staple in Asian countries for at least 5,000 years, and during the Chou dynasty in China (1134-246 B.C.), fermentation techniques were discovered that allowed soy to be prepared in more easily digestible forms such as tempeh, miso, and tamari soy sauce. Tofu was invented in 2nd Century China. Soy was introduced to Europe in the 1700s, and to the United States in the 1800s. Large-scale soybean cultivation began in the United States during World War II. Currently, Midwestern U.S. growers produce approximately half of the world's supply of soybeans. Soy and components of soy called "isoflavones" have been studied scientifically for numerous health conditions. Isoflavones (such as genistein) are believed to have estrogen-like effects in the body, and as a result are sometimes called "phytoestrogens." In laboratory studies, it is not clear if isoflavones stimulate or block the effects of estrogen, or both (acting as "mixed receptor agonists/antagonists"). Synonyms Coumestrol, daidzein, edamame, frijol de soya, genistein, greater bean, haba soya, hydrolyzed soy protein, isoflavone, isoflavonoid, legume, natto, phytoestrogen, plant estrogen, shoyu, soja, sojabohne, soya, soya protein, soybean, soy fiber, soy food, soy product, soy protein Ta-tou , texturized vegetable protein. EvidenceThese uses have been tested in humans or animals. Safety and effectiveness have not always been proven. Some of these conditions are potentially serious, and should be evaluated by a qualified healthcare provider. | Uses based on scientific evidence | Grade* |
|---|
Dietary source of protein Soy products such as tofu are high in protein and are an acceptable source of dietary protein. | A | High cholesterol Numerous human studies report that adding soy protein to the diet can moderately decrease blood levels of total cholesterol and low-density lipoprotein ("bad" cholesterol). Small reductions in triglycerides may also occur, while high-density lipoprotein ("good" cholesterol) does not seem to be significantly altered.Some scientists have proposed that specific components of soybean, such as the isoflavones genistein and daidzein, may be responsible for the cholesterol-lowering properties of soy. However, this has not been clearly demonstrated in research, and remains controversial. It is not known if products containing isolated soy isoflavones have the same effects as regular dietary intake of soy protein.Dietary soy protein has not been proven to affect long-term cardiovascular outcomes such as heart attack or stroke. | A | Diarrhea (acute) in infants and young children Numerous studies report that infants and young children (ages 2 to 36 months) with diarrhea who are fed soy formula experience fewer bowel movements per day and fewer days of diarrhea. This research suggests soy to have benefits over other types of formula, including cow milk-based solutions. The addition of soy fiber to soy formula may increase the effectiveness. Better quality research is needed before a strong recommendation can be made.Parents are advised to speak with a qualified healthcare provider if infants experience prolonged diarrhea, become dehydrated, develop signs of infection such as fever, or experience blood in the stool. A healthcare provider should be consulted for current breastfeeding recommendations, and to suggest long-term formulas with adequate nutritional value. | B | Menopausal hot flashes Soy products containing isoflavones have been studied for the reduction of menopausal symptoms such as hot flashes. The scientific evidence is mixed in this area, with several human trials suggesting reduced number of hot flashes and other menopausal symptoms, but more recent research reporting no benefits. Overall, the scientific evidence does suggest benefits, although better quality studies are needed in this area in order to form a firm conclusion. | B | Breast cancer prevention Several large population studies have asked women about their eating habits, and reported higher soy intake (such as dietary tofu) to be associated with a decreased risk of developing breast cancer. However, this type of research can only be considered preliminary, because people who choose to eat soy may also partake in other lifestyle decisions that may lower the risk of cancer. These other habits, rather than soy, could theoretically be the cause of the benefits seen in these studies (for example, lower fat intake, more frequent exercise, lack of smoking).Until better research is available, it remains unclear if dietary soy or soy isoflavone supplements increase or decrease the risk of developing breast cancer. | C | Cancer treatment Genistein, an isoflavone found in soy, has been found in laboratory and animal studies to possess anti-cancer effects, such as blocking new blood vessel growth (anti-angiogenesis), acting as a tyrosine kinase inhibitor (a mechanism of many new cancer treatments), or causing cancer cell death (apoptosis). In contrast, genistein has also been reported to increase the growth of pancreas tumor cells in laboratory research.Until reliable human research is available, it remains unclear if dietary soy or soy isoflavone supplements are beneficial, harmful, or neutral in people with various types of cancer. | C | Cardiovascular disease Dietary soy protein has not been shown to affect long-term cardiovascular outcomes such as heart attack or stroke. Research does suggest cholesterol-lowering effects of dietary soy, which in theory may reduce cardiovascular risk. Soy has also been studied for blood pressure-lowering and blood sugar-reducing properties in people with type 2 diabetes, although the evidence is not definitive in these areas. Further investigation is needed before a recommendation can be made. | C | Cognitive function A recent study suggests that isoflavone supplementation in postmenopausal women may have favorable effects on cognitive function, particularly verbal memory. Further research is necessary before a firm conclusion can be drawn. | C | Colon cancer prevention There is not enough scientific evidence to determine if dietary intake of soy affects the risk of developing colon cancer. Study results are mixed and more research is needed before a recommendation can be made. | C | Crohn's disease Due to limited human study, there is not enough evidence to recommend for or against the use of soy as a therapy in preventing Crohn's disease. Further research is needed before a recommendation can be made. | C | Cyclical breast pain It has been theorized that the presence in soy of "phytoestrogens" (plant-based compounds with weak estrogen-like properties) such as isoflavones may be beneficial to pre-menopausal women with cyclical breast pain. However, due to limited human study, there is not enough evidence to recommend for or against the use of dietary soy protein as a therapy for this condition. | C | Diarrhea in adults Due to limited human study, there is not enough evidence to recommend for or against the use of soy-polysaccharide/fiber in the treatment of diarrhea. Further research is needed before a recommendation can be made. | C | Endometrial cancer prevention There is not enough scientific evidence to determine if dietary intake of soy affects the risk of developing endometrial cancer. | C | Gallstones (cholelithiasis) Due to limited human study, there is not enough evidence to recommend for or against the use of soy as a therapy in cholelithiasis. Further research is needed before a recommendation can be made. | C | High blood pressure Due to limited human study, the effects of dietary soy on blood pressure are not clear. Further research is necessary before any recommendation can be made. | C | Kidney disease (chronic renal failure, nephrotic syndrome, proteinuria) Due to limited human study, there is not enough evidence to recommend for or against the use of soy in the treatment of kidney diseases such as nephrotic syndrome. People with kidney disease should speak to their healthcare provider about recommended amounts of dietary protein, and should bear in mind that soy is a high protein food. | C | Menstrual migraine One study of a phytoestrogen combination showed a reduced the number of migraine attacks suffered. Further research is needed before a recommendation can be made. | C | Obesity, weight reduction Due to limited human study, there is not enough evidence to recommend for or against the use of soy for weight reduction. Further research is needed before a recommendation can be made. | C | Osteoporosis, post-menopausal bone loss It has been theorized that the presence in soy of "phytoestrogens" (plant-based compounds with weak estrogen-like properties) such as isoflavones may increase bone mineral density in post-menopausal women and reduce the risk of fractures. However, most studies have not been well designed or reported. Until better research is available, a firm conclusion cannot be drawn. Individuals at risk for osteoporosis should speak with a qualified healthcare provider about the therapeutic options for increasing bone mineral density. | C | Prostate cancer prevention Preliminary research has examined the effects of dietary soy intake on prostate cancer development in humans, but results have not been conclusive. Better study is needed before a recommendation can be made. | C | Stomach cancer Preliminary study suggests that intake of soy products may be associated with a reduced risk of death from stomach cancer. Further investigation is needed before a conclusion can be drawn. | C | Type 2 diabetes Several small studies have examined the effects of soy products on blood sugars in people with type 2 ("adult-onset") diabetes. Results are mixed, with some research reporting decreased blood glucose levels, and other trials noting no effects. Overall, research in this area is not well designed or reported, and better information is needed before the effects of soy on blood sugars can be clearly described. | C |
*Key to grades A: Strong scientific evidence for this use; B: Good scientific evidence for this use; C: Unclear scientific evidence for this use; D: Fair scientific evidence against this use; F: Strong scientific evidence against this use. Grading rationale Uses based on tradition or theory The below uses are based on tradition or scientific theories. They often have not been thoroughly tested in humans, and safety and effectiveness have not always been proven. Some of these conditions are potentially serious, and should be evaluated by a qualified healthcare provider. Anemia, anorexia, antifungal, antioxidant, antithrombotic (preventing clots), atherosclerosis, athletic endurance, attention deficit hyperactivity disorder (ADHD), autoimmune diseases, breast enlargement, cancer prevention (general), chronic respiratory problems (cough, phlegm), cystic fibrosis, diabetic neuropathy, fever, gastric cancer, gastrointestinal motility, headache, hepatitis (chronic), inflammation, insect repellant, lymphoma, memory enhancement, nosebleed (chronic), osteosarcoma, pancreatic cancer, premature ovarian failure, rheumatoid arthritis, urinary tract cancer, vaginitis, vasoregulator. Dosing The below doses are based on scientific research, publications, traditional use, or expert opinion. Many herbs and supplements have not been thoroughly tested, and safety and effectiveness may not be proven. Brands may be made differently, with variable ingredients, even within the same brand. The below doses may not apply to all products. You should read product labels, and discuss doses with a qualified healthcare provider before starting therapy. Adults (over 18 years old) Studies have examined regular intake of dietary soy, or 40 to 80 milligrams of isoflavones taken by mouth daily. A soy protein drink (17 grams of soy protein per 200 milliliters) has undergone limited study. A fermented soybean-derived extract tea, various doses of soy protein (such as Abalon®), and up to 7 grams of daily soya fibers taken by mouth have undergone limited study in humans. Soymilk (1,000 milliliters daily for three months) has undergone limited study. 25 to 50 grams of soy protein taken daily by mouth has been studied in people with high cholesterol. Isoflavone content has ranged from 60 to 90 milligrams per day. Cholesterol and low-density lipoprotein levels have been reduced in individuals using 28 grams daily of soy protein with a high isoflavone content, or with Abacor®, a brand that contains 26 grams of soy protein. There is limited study of soymilk (400 milliliters daily) in pre-menopausal women, with reported benefits on cholesterol levels. Isolated soy protein, such as Supro® (60 grams), soy flour (45 grams), and a range of isoflavone products have been studied for menopausal symptoms. Doses of 50 to 75 milligrams of isoflavones have been used in research. Isoflavones/isoflavone-rich soy (60 to 80 milligrams daily by mouth) and soy protein (for example, 40 grams daily of Supro 675®) have also been studied. Children (under 18 years old) Due to potential safety concerns, a qualified healthcare provider should be consulted regarding the choice of infant formula AllergiesSoy can act as a food allergen similar to milk, eggs, peanuts, fish, and wheat.
|